Document is current

Any future updates will be listed below

Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours

Crossref DOI link: https://doi.org/10.1038/s41416-025-03337-2

Published Online: 2026-01-08

Published Print: 2026-01-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark